U

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

Director – Patient Support Services

Business OperationsConfirmed live in the last 24 hours
Full-timeUnited States

About the Job

Requirements

  • A bachelor's degree is required; an MBA is preferred.
  • At least 10 years of pharmaceutical or relevant experience and a history of strong performance are required.
  • Demonstrate proactive communication, innovation, collaboration, analytical skills, and overall business acumen.
  • Have a strong understanding of medical benefit processes and patient and provider access needs involving payers, prior authorizations, and appeals.
  • Be capable of managing and prioritizing multiple priorities.
  • Demonstrate leadership skills and the ability to work effectively in a matrix and unstructured environment.
  • Interact effectively with a broad range of personnel with interpersonal flexibility.
  • Have advanced communication and presentation skills.
  • Have experience leading and managing people and project teams, with or without direct report authority.
  • Be available for occasional travel for required meetings and training.

Responsibilities

  • Ensure exceptional customer experience for access and affordability programs and continuously optimize them to meet the evolving needs of healthcare providers, caregivers, and patients.
  • Oversee daily hub operations and establish, audit, and update program business rules and related documentation.
  • Maintain direct operational oversight of complex buy-and-bill processes, claims reimbursement coding, and medical benefit approvals.
  • Optimize internal hub workflows to reduce administrative friction for offices navigating prior authorization and medical benefit structures.
  • Oversee patient assistance program, copay assistance, and foundation support operations.
  • Collaborate cross-functionally to design stakeholder-centered tools and resources that simplify provider onboarding and enrollment.
  • Act as the primary daily liaison with third-party vendors and track performance metrics, including call volumes, wait times, and benefits investigation turnaround times.
  • Partner with the Data Insights and Analytics team to integrate hub data and provide timely, accurate metrics through the internal data portal.
  • Liaise with the Data Insights and Analytics team to develop and distribute regular summary reports and custom operational reports to internal stakeholders and leadership.
  • Collaborate with the Data Insights and Analytics team to support development of a program-specific view of patient status and journey for field teams.
  • Manage and track the patient access budget, provide timely alerts about potential vendor or program overages, and review invoices for accuracy.
  • Provide brand teams with recommendations on operational changes, cost implications, and tactical plans to address immediate market challenges.
  • Direct the operational interface and maintain open communication between the program and Field Reimbursement Specialist teams to resolve complex claims.
  • Design and execute internal communications and training programs about support program access and affordability options, value proposition, and compliant customer positioning.
  • Collaborate with Corporate Safety to ensure adverse events and product complaints are reported accurately and on time.
  • Serve as the primary operational contact for Corporate Safety, Legal, and Compliance teams during data requests and vendor audits.

Desired Qualifications

  • An MBA is preferred.

About the Company

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

UroGen Pharma develops RTGel-based drug-delivery therapies for urothelial and specialty cancers, commercializing products like Jelmyto and ZUSDURI and advancing a pipeline that includes UGN-102, UGN-103, UGN-104, and UGN-301. Its RTGel platform is liquid at cool temperatures and gels at body temperature, allowing chemotherapy to stay at the treatment site longer for local, sustained exposure. The company differentiates itself by delivering established chemotherapy directly to the disease site to reduce systemic exposure and by building a multi-product portfolio focused on urothelial cancers. Its goal is to improve local treatment outcomes and grow a diversified, globally commercial portfolio through ongoing clinical development and partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Princeton, NJ
Founded
2004

Recently Posted Jobs

Explore more opportunities at UroGen Pharma, Inc

See more jobs